Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
-
Published:2024-08
Issue:
Volume:
Page:
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Buti Maria, Heo JeongORCID, Tanaka YasuhitoORCID, Andreone PietroORCID, Atsukawa MasanoriORCID, Cabezas JoaquínORCID, Chak Eric, Coffin Carla S.ORCID, Fujiwara Kei, Gankina Natalya, Gordon Stuart C., Janczewska EwaORCID, Komori AtsumasaORCID, Lampertico PietroORCID, McPherson StuartORCID, Morozov Vyacheslav, Plesniak RobertORCID, Poulin Sébastien, Ryan Pablo, Sagalova OlgaORCID, Sheng Guoping, Voloshina Natalya, Xie Qing, Yim Hyung JoonORCID, Dixon Susan, Paff MelanieORCID, Felton LeighORCID, Lee Maximilian, Greene Thomas, Lim JessicaORCID, Lakshminarayanan Divya, McGonagle Grant, Plein Helene, Youssef AmirORCID, Elston Rob, Kendrick Stuart, Theodore Dickens
Reference23 articles.
1. World Health Organization. Hepatitis B. 2022 [cited 2023 May 5]; Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b 2. New hepatitis B drug development disillusions: time to reset?;Pawlotsky;Lancet Gastroenterol Hepatol,2023 3. Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV/HDV treatment endpoints conference;Ghany;J Hepatol,2023 4. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection;J Hepatol,2017 5. Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis;Lok;Hepatology,2016
|
|